Tekla Capital Management’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-4,383
| Closed | -$1.02M | – | 209 |
|
|
2020
Q4 | $1.02M | Hold |
4,383
| – | – | 0.04% | 177 |
|
|
2020
Q3 | $960K | Buy |
+4,383
| New | +$960K | 0.04% | 181 |
|
|
2018
Q1 | – | Sell |
-1
| Closed | – | – | 191 |
|
|
2017
Q4 | $0 | Sell |
1
-50,444
| -100% | – | ﹤0.01% | 162 |
|
|
2017
Q3 | $8.31M | Hold |
50,445
| – | – | 0.3% | 64 |
|
|
2017
Q2 | $6.85M | Buy |
50,445
+10,097
| +25% | +$1.37M | 0.25% | 75 |
|
|
2017
Q1 | $7.77M | Buy |
40,348
+6,993
| +21% | +$1.35M | 0.3% | 68 |
|
|
2016
Q4 | $4.7M | Hold |
33,355
| – | – | 0.2% | 82 |
|
|
2016
Q3 | $4.87M | Hold |
33,355
| – | – | 0.19% | 87 |
|
|
2016
Q2 | $3.36M | Hold |
33,355
| – | – | 0.14% | 103 |
|
|
2016
Q1 | $4.46M | Hold |
33,355
| – | – | 0.19% | 93 |
|
|
2015
Q4 | $6.63M | Sell |
33,355
-27,903
| -46% | -$5.55M | 0.24% | 79 |
|
|
2015
Q3 | $9.68M | Buy |
61,258
+29,460
| +93% | +$4.65M | 0.35% | 60 |
|
|
2015
Q2 | $13M | Hold |
31,798
| – | – | 0.47% | 44 |
|
|
2015
Q1 | $14.6M | Buy |
31,798
+22,614
| +246% | +$10.4M | 0.58% | 42 |
|
|
2014
Q4 | $5.16M | Buy |
9,184
+2,386
| +35% | +$1.34M | 0.24% | 71 |
|
|
2014
Q3 | $3.56M | Buy |
+6,798
| New | +$3.56M | 0.17% | 83 |
|